Search Prime Contracts

SPE2DB22D9133-SPE2DB25FYW68

Delivery Order

Overview

Government Description
MALARONE 250-100 MG TABLET 100S
Awarding / Funding Agency
Place of Performance
Park Ridge, IL 60068 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Related Opportunity (Parent Award)
DMS Pharmaceutical Group was awarded Delivery Order SPE2DB25FYW68 (SPE2DB-25-F-YW68) for Malarone 250-100 Mg Tablet 100S worth up to $2,197,485 by Defense Logistics Agency in May 2025. The contract was awarded full & open with NAICS 424210 and PSC 6505 via direct negotiation acquisition procedures. This contract was awarded through vehicle DLA Troop Support Pharmaceutical Prime Vendor (PPV) .

Status
(Closed)

Last Modified 7/17/25
Period of Performance
5/30/25
Start Date
6/2/25
Current End Date
6/2/25
Potential End Date
100% Complete

Obligations
$2.2M
Total Obligated
$2.2M
Current Award
$2.2M
Potential Award
100% Funded

Award Hierarchy

Indefinite Delivery Contract

SPE2DB22D9133

Delivery Order

SPE2DB22D9133-SPE2DB25FYW68

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to SPE2DB22D9133-SPE2DB25FYW68

People

Suggested agency contacts for SPE2DB22D9133-SPE2DB25FYW68

Competition

Number of Bidders
Not Applicable
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Defense Program
None
DoD Claimant Code
None
IT Commercial Item Category
Not Applicable
Awardee UEI
PX72BSBQTKJ3
Awardee CAGE
1UNB0
Agency Detail
Awarding Office
SPE2DB DLA TROOP SUPPORT
Funding Office
SPE2DB
Created By
ebs.sysadmin.dla.mil
Last Modified By
dod_closeout
Approved By
ebs.sysadmin.dla.mil

Legislative

Legislative Mandates
None Applicable
Performance District
IL-09
Senators
Richard Durbin
Tammy Duckworth
Representative
Janice Schakowsky
Modified: 7/17/25